Comparing Levodopa vs Sinemet
Levodopa | Sinemet (carbidopa / levodopa) |
|
---|
Levodopa | Sinemet (carbidopa / levodopa) |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Levodopa inhalation is an inhaled levodopa preparation that may be used to decrease symptoms of slowness, stiffness, or rigidity due to declining plasma levodopa levels in patients with Parkinson's... View more |
Prescription only
Sinemet is a medication that may be used for the treatment of Parkinson's disease that is available in three different strengths: Sinemet 25/100, Sinemet 25/250, and Sinemet 10/100. Dyskinesias... View more |
Related suggestions Restless Legs Syndrome
Parkinson's Disease
Popular comparisons
|
|||||||
More about Levodopa | More about Sinemet (carbidopa / levodopa) | ||||||||
Ratings & Reviews | |||||||||
Levodopa has an average rating of 8.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Sinemet has an average rating of 7.7 out of 10 from a total of 30 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 10% reported a negative effect. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Levodopa side effects |
View all Sinemet side effects |
||||||||
Drug Class | |||||||||
Generic Availability | |||||||||
N/A |
|||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Sinemet prices |
||||||||
Dosage Forms | |||||||||
N/A |
|
||||||||
Brand Names | |||||||||
Dopar, Inbrija | Other carbidopa / levodopa brands include: Atamet, Crexont, Dhivy, Duopa, Parcopa, Rytary | ||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
2.3 hours |
2.3 hours |
||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Category N
Not classified
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 519 drugs are known to interact with Levodopa:
|
A total of 521 drugs are known to interact with Sinemet:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
|
|
||||||||
Disease Interactions | |||||||||
First Approval Date | |||||||||
N/A |
May 02, 1975 |
||||||||
WADA Class View classifications | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient Resources | |||||||||
Professional Resources | |||||||||
N/A |
|||||||||
Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Requip
Requip is used to treat symptoms of Parkinson's disease, such as stiffness, tremors and muscle ...
Mirapex
Mirapex (pramipexole) treats the symptoms of Parkinson's disease and is also used to treat Restless ...
Botox
Botox is used cosmetically to reduce facial lines and wrinkles and for medical purposes for ...
Neupro
Neupro Skin Patches (rotigotine) are used to treat early signs and symptoms of Parkinson's disease ...
Horizant
Horizant (gabapentin enacarbil) is used to treat restless legs syndrome and nerve pain caused by ...
Inbrija
Inbrija is an inhaled medicine used to treat the symptoms of Parkinson's disease. Includes side ...
Rotigotine
Rotigotine is used for parkinson's disease, restless legs syndrome
Gabapentin enacarbil
Gabapentin enacarbil is used for alcohol use disorder, postherpetic neuralgia, restless legs syndrome
Pramipexole
Pramipexole is used for parkinson's disease, periodic limb movement disorder, restless legs ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.